Clinical Trials
3
Active:1
Completed:1
Trial Phases
1 Phases
Early Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Early Phase 1
3 (100.0%)Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms
Early Phase 1
Recruiting
- Conditions
- Neoplasms
- First Posted Date
- 2022-07-26
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Instituto de Medicina Regenerativa
- Target Recruit Count
- 100
- Registration Number
- NCT05475106
- Locations
- 🇲🇽
Instituto de Medicina Regenerativa, Tijuana, Baja California, Mexico
Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms
Early Phase 1
Completed
- Conditions
- Neoplasms
- First Posted Date
- 2020-08-11
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Instituto de Medicina Regenerativa
- Target Recruit Count
- 30
- Registration Number
- NCT04509167
- Locations
- 🇲🇽
Instituto de Medicina Regenerativa, Tijuana, Baja California, Mexico
Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19
Early Phase 1
Active, not recruiting
- Conditions
- ARDS, HumanCovid-19
- First Posted Date
- 2020-07-02
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Instituto de Medicina Regenerativa
- Target Recruit Count
- 9
- Registration Number
- NCT04456361
- Locations
- 🇲🇽
Instituto de Medicina Regenerativa, Tijuana, Baja California, Mexico
News
No news found